Table 1.
Univariate and multivariate Cox analysis of SigIQGAP3NW for PFS in PC.
| Factors |
Univariate Cox Analysis |
Multivariate Cox Analysis |
||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p-value | HR | 95% CI | p-value | |
| Sig 1 | 2.72 | 2.14–3.45 | <2e-16*** | 1.83 | 1.33–2.52 | 0.0002*** |
| Age 2 | 1.02 | 0.99–1.05 | 0.189 | 0.99 | 0.96–1.02 | 0.491 |
| WHO GG2 3 | 3.53 | 0.48–27.64 | 0.219 | 3.33 | 0.43–25.69 | 0.248 |
| WHO GG3 | 5.27 | 0.69–40.57 | 0.110 | 4.01 | 0.51–31.43 | 0.185 |
| WHO GG4 | 9.76 | 1.28–74.61 | 0.028* | 6.44 | 0.82–50.54 | 0.076 |
| WHO GG5 | 21.34 | 2.96–154.5 | 0.002** | 10.6 | 1.4–80.16 | 0.022* |
| Margin 4 | 2.3 | 1.52–3.48 | 8.1e-5*** | 1.26 | 0.8–2.0 | 0.317 |
| Stage 5 | 3.69 | 2.08–6.52 | 7.45e-6*** | 1.59 | 0.83–3.06 | 0.164 |
SigIQGAP3NW score; 2 Age at diagnosis; 3 WHO grade group (GG) 2–5 in comparison to WHO GG1; 4 Compared to no surgical margin status; 5 Stage 3 + 4 in comparison to Stage 1 + 2; *, **, *** for p < 0.05, 0.01, and 0.001 respectively.